The federal government has launched a two-stage compensation package covering wage losses or medical expenses in the range of $50 million to $20,000. If death occurs, the compensation will be higher. The report from
said that the plan will be divided into two levels. The first level will provide compensation for medical expenses or income losses of up to AUD 5,000 and up to AUD 20,000 to anyone who can prove that they have adverse reactions due to COVID-19 vaccination and pay for treatment out of their own pocket.
second level will provide more than 20,000 Australian dollars in compensation to the families of those who die of heart disease due to thrombosis due to Oxford vaccine vaccination and mRNA vaccine ( Pfizer or Modena vaccine).
To apply for compensation, a doctor must provide a certificate to confirm that the applicant has one or more vaccination-related symptoms.
To apply for the first level of compensation, the applicant must be hospitalized for at least one night and provide proof of medical expenses or wage losses. The details about the second level of compensation have not been finalized.
Currently, there are more than 25 countries around the world, such as the United States, the United Kingdom, Germany, Japan and New Zealand , which have launched a non-negligent vaccine compensation plan. Some countries have implemented it for more than 30 years, but Australia has never launched a similar plan.
The other countries' plans cover all vaccines recognized by the country's government, but in Australia, the plan only targets the new crown vaccine.
reported that although the side effects of the vaccine are extremely rare, they do occur.
According to data from the Australian Drug Treatment Administration (TGA), more than 1,100 serious adverse reactions occurred in the 31 million doses of the new crown vaccine injected across Australia.
Pfizer vaccine is related to 269 suspected myocarditis and concurrent pericarditis , and is related to 725 suspected verticulitis.
Modena vaccine is related to 1 suspected myocarditis and 13 suspected pericarditis. The Oxford vaccine was associated with 152 cases of thrombocytopenia syndrome (TTS), and eight people died. In Australia, the risk of dying from TTS after vaccination is about one in a million.
